![](/img/cover-not-exists.png)
Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non-Small-Cell Lung Cancer
Blumenschein, G. R., Gatzemeier, U., Fossella, F., Stewart, D. J., Cupit, L., Cihon, F., O'Leary, J., Reck, M.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.22.0541
Date:
September, 2009
File:
PDF, 397 KB
english, 2009